166 related articles for article (PubMed ID: 22231733)
1. Expression of interleukin-8 receptor CXCR2 and suppressor of cytokine signaling-3 in astrocytic tumors.
Korkolopoulou P; Levidou G; El-Habr EA; Adamopoulos C; Samaras V; Zisakis A; Kavantzas N; Boviatsis E; Fragkou P; Papavassiliou AG; Patsouris E; Piperi C
Mol Med; 2012 May; 18(1):379-88. PubMed ID: 22231733
[TBL] [Abstract][Full Text] [Related]
2. The role of CXC-chemokine receptor CXCR2 and suppressor of cytokine signaling-3 (SOCS-3) in renal cell carcinoma.
Stofas A; Levidou G; Piperi C; Adamopoulos C; Dalagiorgou G; Bamias A; Karadimou A; Lainakis GA; Papadoukakis S; Stravodimos K; Dimopoulos MA; Patsouris E; Gakiopoulou H; Korkolopoulou P
BMC Cancer; 2014 Mar; 14():149. PubMed ID: 24593195
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of IL-6, IL-8/CXCR2 axis, Tyr p-STAT-3, and SOCS-3 in lymph nodes from patients with chronic lymphocytic leukemia: correlation between microvascular characteristics and prognostic significance.
Levidou G; Sachanas S; Pangalis GA; Kalpadakis C; Yiakoumis X; Moschogiannis M; Sepsa A; Lakiotaki E; Milionis V; Kyrtsonis MC; Vassilakopoulos TP; Tsirkinidis P; Kontopidou F; Kokoris S; Siakantaris M; Angelopoulou M; Papadaki H; Kavantzas N; Panayiotidis P; Patsouris E; Korkolopoulou P
Biomed Res Int; 2014; 2014():251479. PubMed ID: 24883303
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of IL-8-STAT-3 pathway in astrocytomas: correlation with IL-6, VEGF and microvessel morphometry.
Piperi C; Samaras V; Levidou G; Kavantzas N; Boviatsis E; Petraki K; Grivas A; Barbatis C; Varsos V; Patsouris E; Korkolopoulou P
Cytokine; 2011 Sep; 55(3):387-95. PubMed ID: 21684758
[TBL] [Abstract][Full Text] [Related]
5. STAT3 genotypic variation and cellular STAT3 activation and colon leukocyte recruitment in pediatric Crohn disease.
Willson TA; Kuhn BR; Jurickova I; Gerad S; Moon D; Bonkowski E; Carey R; Collins MH; Xu H; Jegga AG; Guthery SL; Denson LA
J Pediatr Gastroenterol Nutr; 2012 Jul; 55(1):32-43. PubMed ID: 22197944
[TBL] [Abstract][Full Text] [Related]
6. Analysis of interleukin (IL)-8 expression in human astrocytomas: associations with IL-6, cyclooxygenase-2, vascular endothelial growth factor, and microvessel morphometry.
Samaras V; Piperi C; Levidou G; Zisakis A; Kavantzas N; Themistocleous MS; Boviatsis EI; Barbatis C; Lea RW; Kalofoutis A; Korkolopoulou P
Hum Immunol; 2009 Jun; 70(6):391-7. PubMed ID: 19332096
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas.
Lee TL; Yeh J; Van Waes C; Chen Z
Mol Cancer Ther; 2006 Jan; 5(1):8-19. PubMed ID: 16432158
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.
Lejeune D; Demoulin JB; Renauld JC
Biochem J; 2001 Jan; 353(Pt 1):109-116. PubMed ID: 11115404
[TBL] [Abstract][Full Text] [Related]
9. Correlative analyses of the expression levels of PIAS3, p-SHP2, SOCS1 and SOCS3 with STAT3 activation in human astrocytomas.
Liu LH; Li H; Cheng XX; Kong QY; Chen XY; Wu ML; Li Y; Liu J; Li C
Mol Med Rep; 2017 Feb; 15(2):847-852. PubMed ID: 28035384
[TBL] [Abstract][Full Text] [Related]
10. SOCS 3 and PPAR-gamma ligands inhibit the expression of IL-6 and TGF-beta1 by regulating JAK2/STAT3 signaling in pancreas.
Yu JH; Kim KH; Kim H
Int J Biochem Cell Biol; 2008; 40(4):677-88. PubMed ID: 18035585
[TBL] [Abstract][Full Text] [Related]
11. Duffy antigen receptor for chemokines (DARC) expressing in cancer cells inhibits tumor progression by suppressing CXCR2 signaling in human pancreatic ductal adenocarcinoma.
Maeda S; Kuboki S; Nojima H; Shimizu H; Yoshitomi H; Furukawa K; Miyazaki M; Ohtsuka M
Cytokine; 2017 Jul; 95():12-21. PubMed ID: 28214673
[TBL] [Abstract][Full Text] [Related]
12. Sustained IL-6/STAT-3 signaling in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing.
Isomoto H; Mott JL; Kobayashi S; Werneburg NW; Bronk SF; Haan S; Gores GJ
Gastroenterology; 2007 Jan; 132(1):384-96. PubMed ID: 17241887
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of signal transducer and activator of transcription (STAT-3 and STAT-5) transcription factors and alteration of suppressor of cytokine signaling (SOCS-1) protein in prostate cancer.
Singh N; Hussain S; Bharadwaj M; Kakkar N; Singh SK; Sobti RC
J Recept Signal Transduct Res; 2012 Dec; 32(6):321-7. PubMed ID: 23134344
[TBL] [Abstract][Full Text] [Related]
14. Lymph node metastasis is mediated by suppressor of cytokine signaling-3 in gastric cancer.
Deng J; Jiao X; Liu H; Wu L; Zhang R; Wang B; Pan Y; Hao X; Liang H
Tumour Biol; 2013 Dec; 34(6):3627-36. PubMed ID: 23824571
[TBL] [Abstract][Full Text] [Related]
15. Acute alcohol intake induces SOCS1 and SOCS3 and inhibits cytokine-induced STAT1 and STAT3 signaling in human monocytes.
Norkina O; Dolganiuc A; Catalano D; Kodys K; Mandrekar P; Syed A; Efros M; Szabo G
Alcohol Clin Exp Res; 2008 Sep; 32(9):1565-73. PubMed ID: 18616672
[TBL] [Abstract][Full Text] [Related]
16. Molecular basis for the critical role of suppressor of cytokine signaling-1 in melanoma brain metastasis.
Huang FJ; Steeg PS; Price JE; Chiu WT; Chou PC; Xie K; Sawaya R; Huang S
Cancer Res; 2008 Dec; 68(23):9634-42. PubMed ID: 19047140
[TBL] [Abstract][Full Text] [Related]
17. Impact of STAT/SOCS mRNA expression levels after major injury.
Brumann M; Matz M; Kusmenkov T; Stegmaier J; Biberthaler P; Kanz KG; Mutschler W; Bogner V
Mediators Inflamm; 2014; 2014():749175. PubMed ID: 24648661
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of vascular endothelial growth factor A, its receptors VEGFR-1, -2, and -3 and co-receptors neuropilin-1 and -2 does not predict bevacizumab response in human astrocytomas.
Baumgarten P; Blank AE; Franz K; Hattingen E; Dunst M; Zeiner P; Hoffmann K; Bähr O; Mäder L; Goeppert B; Machein M; Seifert V; Steinbach JP; Plate KH; Harter PN; Mittelbronn M
Neuro Oncol; 2016 Feb; 18(2):173-83. PubMed ID: 26627848
[TBL] [Abstract][Full Text] [Related]
19. Expression of STATs and their inhibitors SOCS and PIAS in brain tumors. In vitro and in vivo study.
Ehrmann J; Strakova N; Vrzalikova K; Hezova R; Kolar Z
Neoplasma; 2008; 55(6):482-7. PubMed ID: 18999875
[TBL] [Abstract][Full Text] [Related]
20. Combining TMZ and SB225002 induces changes of CXCR2 and VEGFR signalling in primary human endothelial cells
Urbantat RM; Jelgersma C; Vajkoczy P; Brandenburg S; Acker G
Oncol Rep; 2022 Sep; 48(3):. PubMed ID: 35856448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
